Asimenia Angelidou MD PhD
Attending Neonatologist, Beth Israel Deaconess Medical Center; Scientist, Precision Vaccines Program, Boston Children's Hospital; Assistant Professor in Pediatrics, Harvard Medical School
Join to View Full Profile
330 Brookline AveBoston, MA 02215
Phone+1 617-919-4671
Dr. Angelidou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Asimenia Angelidou is an Assistant Professor in Pediatrics at Harvard Medical School specializing in Neonatology/Perinatology. She completed her fellowship in Neonatal-Perinatal Medicine at Boston Children’s Hospital and her residency in Pediatrics at the University of Texas Southwestern and Children's Medical Center in Dallas, TX. She holds medical and doctoral degrees from the University of Athens. Since 2017, she has served as an Attending Neonatologist at Boston Children's Hospital, Beth Israel Deaconess Medical Center and Winchester Hospital. Additionally, Dr. Angelidou is a Faculty Scientist and Clinical Lead at the Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital. Her research focuses on topics including neonatal immune ontogeny, vaccine-induced trained immunity and maternal-infant health.
Education & Training
Boston Children's Hospital/Tufts Medical CenterFellowship, Neonatal-Perinatal Medicine, 2014 - 2017
University of Texas Southwestern Medical CenterResidency, Pediatrics, 2011 - 2014
University of AthensClass of 2008
Certifications & Licensure
MA State Medical License 2014 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Publications & Presentations
PubMed
- A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New Guinea.Joann Diray-Arce, Caitlin Syphurs, Annmarie Hoch, Kerry McEnaney, Kinga K Smolen
The Journal of Allergy and Clinical Immunology. Global. 2026-05-01 - Higher Promoter Methylation of the Ubiquitin-Associated and SH3 Domain Containing A (UBASH3A) Gene Is Associated With T-Lymphocyte Ontogeny and Reduced Susceptibility ...Ziyi Wang, Nelly Amenyogbe, Rym Ben-Othman, Bing Cai, Mandy Lo
The Journal of Infectious Diseases. 2026-03-17 - Immune Development in Early Life (IDEaL) longitudinal cohort study protocol: Identifying biomarkers of vaccine responsiveness, respiratory infection, and asthma.Donato Amodio, Chiara Rossetti, Asimenia Angelidou, Marco Sanna, Silvia Cellini
The Journal of Allergy and Clinical Immunology. Global. 2025-11-01
Press Mentions
Newborns of Socially Vulnerable Mothers at Higher Risk of COVID-19 InfectionApril 26th, 2021- Study Reveals Mother-to-Newborn COVID-19 Infection Rates Are Low but Indirect Risks ExistApril 23rd, 2021
BCG Vaccine Formulations Vary Widely in Their Characteristics, Study ShowsJanuary 28th, 2020
Grant Support
- Immunometabolic signatures of BCG-induced neonatal trained immunityBETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
